Clinical Trials Browser

Phase 1/2 × Vemurafenib × Gastrointestinal × Clear all

NCT04790448 2023-02-15

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Cancer Metastatic